Published in
BioMed Central, Journal of Translational Medicine, 1(17), 2019
DOI: 10.1186/s12967-019-1828-0
Links
Tools
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
Journal article published in 2019 by
M. G. Dal Bello 
,
R. A. Filiberti,
A. Alama ,
A. M. Orengo,
M. Mussap ,
S. Coco,
I. Vanni,
S. Boccardo,
E. Rijavec,
C. Genova,
F. Biello ,
G. Barletta,
G. Rossi,
M. Tagliamento ,
C. Maggioni
and other authors.
,
R. A. Filiberti,
A. Alama ,
A. M. Orengo,
M. Mussap ,
S. Coco,
I. Vanni,
S. Boccardo,
E. Rijavec,
C. Genova,
F. Biello ,
G. Barletta,
G. Rossi,
M. Tagliamento ,
C. Maggioni
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 